# Dual tumour–myeloid targeting of glioblastoma with GPNMB CAR-T cells

> **Newsylist Open Intelligence Dossier** · First detected: 2026-07-01 21:33 UTC · Category: Health · Sources: 14 · Current Velocity: 14.03

## Executive Summary
Researchers are testing a dual-targeting GPNMB CAR-T cell therapy to treat aggressive glioblastoma and its supporting immune cells.

## Intelligence Brief
A new immunotherapy strategy utilizing GPNMB CAR-T cells is being developed to combat aggressive glioblastoma. This approach employs dual targeting to attack both the brain tumors and their myeloid immune cell accomplices.


Coverage from Nature, Medical Xpress, and Labmate-Online emphasizes the use of cytokine-armoured cells and the potential for this therapy to eliminate deadly brain cancers. The Telegraph and News-Medical further highlight the promise of this immunotherapy in treating one of the deadliest forms of cancer.


Future developments will center on the effectiveness of these CAR-T cells in eliminating glioblastoma and the impact of the cytokine-armoured delivery system.

## Verified Facts & Key Claims
### What is the specific target of this CAR-T therapy?
The therapy uses GPNMB CAR-T cells for dual tumour-myeloid targeting.

### What makes this immunotherapy strategy different?
According to coverage, the strategy targets both the aggressive brain tumors and their immune cell accomplices using cytokine-armoured cells.

### Which condition is this treatment designed to address?
The therapy is designed to treat glioblastoma, described in coverage as an aggressive and deadly brain cancer.

## Key People, Organizations & Locations
Deadliest, GPNMB CAR-T, CAR-T, Cytokine-armoured CAR T

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| Oncodaily | Beeta Benjy: What is the Missing Puzzle Piece of CAR-T Therapy Failure in Solid Tumors? | 2026-07-01 23:01 | [Source Link](https://news.google.com/rss/articles/CBMiW0FVX3lxTE02SlFpMGtSc1FSNEZOT3VIX0pNMmVqVW1BNWxmUm1CNV9NVzRiR2pmVE9fallmRkxBWi1ZZlE5LXZqSVZEM3RrMzJyd29nckZHRU1fM0RvQXNTd3c?oc=5) |
| Labroots | Engineered Immunotherapy Improves Treatment for Brain Cancer | 2026-07-01 23:01 | [Source Link](https://news.google.com/rss/articles/CBMiqwFBVV95cUxQVms5bk1ERmVXLUp6dlVFZ0xSX0lCWW41VzZ4alJvSVY3ZV9lc19EbW5pYkJsb0pETXIzREUyNFE4TVRVbC13Rzgyd1BKZGdmT0JiU1hPTE51ZERDejZ4VWVYQ09UMFVrU3VJdU5EelFiNGhUVGsyeWhTN1hMU2MtbFhBV05LNzJyeDRIYUtjQldZY1FZNDVwN2lfdFJ6ZlJJVUVyTnA3RDBsNTDSAbABQVVfeXFMTUJ3cE5EazAwaFNXMjE4eTJ3TVAyaTZxN3gtc3JaVWJnaV8yc0d2dzVLdWRVQnRzNkdDYnhDbTZKQVRKaFAzTkpVZ1ZZUks5U2JkOTRrbnZTMExOSFVCU3lfQkNCV0puNFNzNEluSUJzamJ2YVI2NVN4SXJQZVdYQmE4bWhVcDhVYUNKM1dnclJYQ29WVVZ0ZjlFS0ZTTkJGTzRkQy1QVUw) |
| Inside Precision Medicine | CAR T Cells Simultaneously Target Glioblastoma and Immune Cells | 2026-07-01 23:01 | [Source Link](https://news.google.com/rss/articles/CBMivAFBVV95cUxNR3FLOGE1ZXIzYXFmSUotQzRPbkVGdHBmdU5rRF9jVmhyQXRFV05OWmJ0OWxLMVhJdWwtc0pva3RseTd3RXdQaGVyMWFBaE1JWnJMVXp2Y2E3YzFPb05UR1BvZTJrd3pBNmhXczdhUTZnckNid0FsRE4wTk5maUg5dDJfbWhuSFBsLWZ2bkIwbHZ2dlVYSEIyQ0hua0k3eWZEem1OczZCcW84dV9pVjRmMEhkbDVhVnJpR1NMeQ?oc=5) |
| Newsweek | New Therapy Could Target One of the Deadliest Brain Cancers | 2026-07-01 23:01 | [Source Link](https://news.google.com/rss/articles/CBMimAFBVV95cUxQNFNOWnhWODdoV29VdVBDdzdiNmtEcXFtcmdFVll6aGlSZExNUXpXT0toV0F4eXFZbXNZU0U1X3dZd3Z4bWZRZ0FBU21hTHczM21sdzVraFl3M1VnS1NQQmdMR0xVN1pjT1BaVk9LN1RmU2x0YlozdFFJVGlHVDhPS1RqUk52ZHh4ZmVleE9BbnFJV0ZRNzBHUA?oc=5) |
| University of Calgary | Community giving powers a UCalgary cancer immunotherapy breakthrough | 2026-07-01 23:01 | [Source Link](https://news.google.com/rss/articles/CBMilwFBVV95cUxQUTBLN0MtLW02NjZGSS1reWhNcnhocHVhOC1aOVJlbnZLVm1jS2lvc1VDM05CbW1GZWNpRVBiVkY1c1pvQkt0aDdHcE9zbTlYeXRpMS0tRjBpZ1BQUGx6dHBSOHhaLThJZG1jVm1rRDdjMWlNRnBDWVplb3o2RUppTXI0eF9RWGxUQ1Vwa19UMnhMX0tQOFBj?oc=5) |
| Calgary Herald | U of C-developed experimental treatment reduces rare cancerous tumours | 2026-07-01 23:01 | [Source Link](https://news.google.com/rss/articles/CBMisgFBVV95cUxOMEtkaXFmVlNYckR3eDFsRUlnQXBSS2w2OUpOLVF4NTlOOExSVjk0V1EzTlluN2VPZUxNUDNOVUhqTncwTWpIRkd3ZVBSX2hlV3pSczJHQXQxSk5RZEt4bUdkTmg5Q3YtMElfRDdhMHgyYTdEeGYzcG1IbzhwNjFhUG5CcHNNbjJrWU5sZjVqTHc3WW9mMVV4cUlvak83Y2FzZU44TERic0pxNVZ4WWZtTVZ3?oc=5) |
| University of Calgary | New immunotherapy developed at the University of Calgary being used to treat solid cancerous tumours | 2026-07-01 23:01 | [Source Link](https://news.google.com/rss/articles/CBMisgFBVV95cUxQWkdxZGJqaUltV25LcDVhYjNlY0g1dkpLUG1KMDRnQl94MUtOOG50aE9RUTJ2eHlLbnRKTFd2Tzh3eVBBZTZWYUd6amcyVlR5WTFNbkVicE44UUJPSmdWVHBwZ1YzcG90WE5wQ2VjYmM2dm1VaGtWQUtvVGpEY09BdGxOcGdPVWZaMUQwQUY1VDZqdXFJMzIxSEN0eE9mR3lNS0QybEJ1SmRhcWlYZW9GWlJR?oc=5) |
| BioWorld News | With GPNMB, CAR T makes further inroads in solid tumors | 2026-07-01 23:01 | [Source Link](https://news.google.com/rss/articles/CBMimwFBVV95cUxNZ2Z1SUowaXZGNlRqdFlmZm9lOXN0QUt1cFNNNkx0OE96Ym9XS2ZmcTF4QWc0QnEtb3JGVHJDb2R5OGVxbU9tdnNrd1JSRmVEZUpoU3M4RUllTHBRS1lMMlFEUEtSZE9zMERVSU9sOWlseDZZSnlzMUdKNkQ3d3NNaTJGaVNiTXV0Yi1TcUxTSGNVRFFURG9ENExuUQ?oc=5) |
| Northwestern University | Immunotherapy Strategy Shows Promise for Deadly Brain Cancer | 2026-07-01 22:18 | [Source Link](https://news.google.com/rss/articles/CBMisAFBVV95cUxQLU16S3F3UU5ldXotcjFEYUtXTDNJR1pTd3V1RVFKU1VYN2ZPQ09sdUMtaDhGYW1NS2JUNUFmU05Cd2RJMmE4X3VMSmt2QWVXdmdBaDBSUnF6OWFZSi1vT09rOUp0SlBtaDhqaFFvUnRIRlIzb2s0Z0JhUlZvZi1sV054a0syVWJiUmYxbG8yTkJVT3FWVnRIa2NMV2h6MVVGeFZDRXIyc0FsNzVQR3NqNg?oc=5) |
| Newswise | McMaster-Developed Immunotherapy Strategy Targets Aggressive Brain Tumours and Their Fuel | 2026-07-01 22:18 | [Source Link](https://news.google.com/rss/articles/CBMiwAFBVV95cUxOaUgyYk0zakIyMWRQM1hsRFI1R3hQbElLbmdfZEROQkxReExsNlRFY3ZycWNWOUZYVDVPUkt1T2FhT19WckYzOVlXMEJIZGU3UFozeG9uM21Rek8wT1hVUlJhXzNRcWNodXRfTHB3X3NCenJRSDkxSHI0bkdqZGs4aTU2VU9SRDV1c1BiaG9tMDBJSkVPbFR0cU4tdWY2UDljb1JiOFZMOFA1VDg5X1BNOGsyU1VwSU5DRzBHTEZ3TjHSAcABQVVfeXFMTmlIMmJNM2pCMjFkUDNYbERSNUd4UGxJS25nX2RETkJMUXhMbDZURWN2cnFjVjlGWFQ1T1JLdU9hYU9fVnJGMzlZVzBCSGRlN1BaM3hvbjNtUXpPME9YVVJSYV8zUXFjaHV0X0xwd19zQnpyUUg5MUhyNG5HamRrOGk1NlVPUkQ1dXNQYmhvbTAwSUp) |
| News-Medical | CAR-T cell therapy shows potential to eliminate aggressive glioblastoma | 2026-07-01 22:18 | [Source Link](https://news.google.com/rss/articles/CBMiuwFBVV95cUxNdE9QMzZLNldNcy13cDh0RkhtM19VQXQwaUt6UlR3N2xyZUE2WDJvU01xTHd3SFpodDh0cXFWcjZmUnpaaTF0eDJTTEdGdmZoZ0MtVjhXdXVvMXFQWWxqTjl3YkpsNnFhRnVPQzV5ajYzcEtyTHBIaFhQVTF1VXlmZjE3UkFwM2sxSnRQUWpUSy1fQ1NIRmRYb3FSaFhvdXpQWXZBSTZNN2tfbTNmSm41UDI5Ql9BczBLYnZv?oc=5) |
| Labmate-Online | Cytokine-armoured CAR T therapy shows promise against aggressive glioblastoma | 2026-07-01 22:18 | [Source Link](https://news.google.com/rss/articles/CBMi9AFBVV95cUxQa1ZNSkV4Y2ZYaWpYNUxQamFpclk1bm1KRTZ2aXlISy1aT01rYmJHR0l2YzRheHFpbEN1SDBKeDNiY2NwQWNvVnphUndPYm14d2hxMlRlVDZOTjhRR2lhUWNFNzNkMUZQWmNySVRGSUxtMW9QVWVfWUtZdjZMVEhtdGdOaGU0N082VXlTQ1dISllaWUFzSnczR3F1aVdhVTVZbEdKX2kzVTM0N2VEMnYwT0QzZ0FoSWlzbmwzbG1IYjV0aFVjQzRJSGpUVzc5eWlNOHp3MzZHa0l4R2NCUlU3SFpNT29Db0UwNUQ2Wm9YWkd6TDlC?oc=5) |
| Medical Xpress | New immunotherapy strategy targets aggressive brain tumors and their immune cell accomplices | 2026-07-01 22:18 | [Source Link](https://news.google.com/rss/articles/CBMilAFBVV95cUxNZTFRWFI0Ujg4QS1aSmUtMUtWb1BVMGhkeEFyRVVJZjg0MFFLTjJEckhPNm5hSnQ0T3cxT0VlWnFQRWtYUWRUcVRjLWpLM09aZVFvT2JNaEZobEF2a2hQR2ZvZHVHb3dqbW42NDRUX2poTTViQ19HWHpCR3JRSUJNZnQtX2Fhc2NSaHJWcnZLdkRjTnRh?oc=5) |
| The Telegraph | Deadliest brain cancer could be treated with immunotherapy | 2026-07-01 22:18 | [Source Link](https://news.google.com/rss/articles/CBMipgFBVV95cUxNUDhzdk16N2l6aGcwUmRZLVR1Uko0aS0xTEk4WENKM3V0d3E3WUN4UDZmTFMwS2twSWhEcHZWV1lLcHg1azFtcGMzVTI1R01ielpGYVYyLWhZM2pjRUpPcTgwWmNHZ25jMUlId3g2UnVpN1NoMUgwM0tBOEFMNmtGYWpMaFJoenFwc1VRcVY3RUo1TnNuM2l4NmUwd1YzNVdLTG9sMFdR?oc=5) |
| Nature | Dual tumour–myeloid targeting of glioblastoma with GPNMB CAR-T cells | 2026-07-01 22:18 | [Source Link](https://news.google.com/rss/articles/CBMiX0FVX3lxTFA2NmhWU0lFU255TGtVRGtpNmU2OF85a1VyVEZXMjVqNGVPSGtPazFqc3l1aUZ4ckFfckY1cHllZ25oWWNiOGlzZW94dkJCZDZMMWhHTFpkeW10RzdzVERr?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-07-01/dual-tumour-myeloid-targeting-of-glioblastoma-with-gpnmb-car-t-cells*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*